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Summary
Overexpression of Dishevelled (Dvl), an essential compo-
nent of the Wnt signaling pathway, is frequently associated
with tumors [1, 2], and thus the Dvl protein level must be
tightly controlled to sustain Wnt signaling without causing
tumors. Kelch-like 12 (KLHL12) targets Dvl for ubiquitination
and degradation [3], suggesting its potential importance in
avoiding aberrant Dvl overexpression. However, the regula-
torymechanism of the KLHL12 activity remained elusive. We
show here that nucleoredoxin (NRX) determines the Dvl
protein level, which is revealed by analyses on NRX2/2
mice showing skeletal and cardiovascular defects. Consis-
tent with the previously reported Dvl-inhibiting function
of NRX [4], Wnt/b-catenin signaling is hyperactivated in
NRX2/2 osteoblasts. However, the signal activity is sup-
pressed in cardiac cells, where KLHL12 is highly expressed.
Biochemical analyses reveal that Dvl is rapidly degraded by
accelerated ubiquitination in NRX2/2 mouse embryonic
fibroblasts, and they fail to activate Wnt/b-catenin signaling
in response to Wnt ligands. Moreover, experiments utilizing
purified proteins show that NRX expels KLHL12 fromDvl and
inhibits ubiquitination. These findings reveal an unexpected
function of NRX, retaining a pool of inactive Dvl for robust
activation of Wnt/b-catenin signaling upon Wnt stimulation.
Results and Discussion
NRX Knockout Is Perinatally Lethal
We previously reported that nucleoredoxin (NRX) directly
binds to Dishevelled (Dvl) and inhibits its signaling function in
culture cells [4]. To further elucidate the function of NRX
in vivo, we generated NRX knockout mice. A redox-catalytic
motif (WCPPC) in NRX is essential for NRX-Dvl interaction
and Wnt/b-catenin signaling suppression [4]. Therefore, we
targeted exons 3 and 4, which include the coding region of
this catalytic motif, by homologous recombination using a
gene cassette containing LacZ and neomycin-resistance*Correspondence: hmiki@protein.osaka-u.ac.jp
4Present address: Department of Kidney Development, Institute of Molec-
ular Embryology and Genetics, Kumamoto University, Honjo, Kumamoto
860-0811, Japangenes (see Figure S1A available online). Successful recombi-
nation was confirmed by Southern blotting (Figure S1B).
We found that NRX knockout is perinatally lethal (Fig-
ure S1C)—a result consistent with a previously reported
finding about mice carrying hypomorphic NRX alleles with
a splice-site mutation [5].
Aberrant Activation of Wnt/b-Catenin Signaling
in Osteoblasts from NRX2/2 Mice
On embryonic day (E) 18.5,NRX2/2 embryoswere smaller than
their NRX+/+ littermates (Figure S1D). Further, many of them
exhibited craniofacial defects with short frontal regions. By
staining the bones and cartilages of the embryos, we con-
firmed that their frontal bones were significantly shorter than
those of their NRX+/+ littermates (Figure 1A). Further analyses
of the bone preparations revealed sternal defects (Figure S1E).
Similar defects in the frontal bones and the sternum have
been reported to occur in mouse knockouts of Axin2 [6] and
GSK3b [7], which are also suppressors of Wnt/b-catenin
signaling. These phenotypic abnormalities appear to be con-
sistent with the inhibitory role of NRX in Wnt/b-catenin
signaling.
Yu et al. reported that the craniofacial defects in Axin22/2
mice are due to the aberrant activation of Wnt/b-catenin
signaling and the resultant excessive osteoblast differentiation
and premature ossification and suture closure [6]. Therefore,
we assessed differentiation of cells isolated from calvaria of
E18.5 embryos. As expected, differentiated osteoblasts were
more numerous in the cells from NRX2/2 embryos than in the
cells from NRX+/+ littermates (Figure 1B). Immunoblotting
with an antibody that recognizes the activated b-catenin (ABC)
showed that the Wnt/b-catenin pathway was more strongly
activated in the cells from the NRX2/2 embryos (Figure 1C).
We then determined whether NRX is expressed in the frontal
bone region in vivo. Because the targeted allele includes
LacZ, whose expression is controlled by the NRX gene pro-
moter, we performed LacZ staining of E18.5 embryos and
detected positive signals in the frontal bone region (Figure 1D).
Immunostaining with the anti-ABC antibody yielded stronger
signals for cells in this region. These cells were confirmed as
osteoblasts by immunostaining for Runx2, an osteoblast
marker (Figure 1E). To further validate the activation of Wnt/
b-catenin signaling, we also performed immunostaining for
collagen I, a direct transcriptional target for b-catenin [8]. As
shown in Figure 1F, we observed a clear augmentation of
collagen I signals in the bone region. Collectively, these results
suggest that the abnormal bone morphology in NRX2/2 mice
may be caused by aberrant activation of Wnt/b-catenin
signaling.
Microarray Transcriptome Analyses
To further explore the defects of NRX2/2 mice, we performed
microarray analyses of E9.5 and E11.5 embryos. No known
target genes of Wnt/b-catenin signaling were commonly upre-
gulated in NRX2/2 mice, but several target genes, such as
Fzd2 and Occludin [9], were rather commonly downregulated
(Figure S2A). Furthermore, several other target genes, such
as TCF1 and Brachury(T) [9, 10], were also downregulated in
Figure 1. Aberrant Differentiation of Osteoblasts in NRX2/2 Mice
(A) The cranial region of the skeletal preparations of E18.5 embryos stained by Alizarin red and Alcian blue. The green line is set at the anterior end of the
NRX2/2 skull.
(B) Cells isolated from calvaria of E18.5 embryos were cultured for 5 days in mock media or differentiation media, and differentiated osteoblasts were visu-
alized by alkaline phosphatase staining. Magnified images are also indicated below.
(C) Cells isolated and treated as described in (B) were harvested, and the lysates were subjected to immunoblotting with the indicated antibodies.
(D) Sections of E18.5 embryos were subjected to LacZ staining. The boxed areas are magnified and indicated at the bottom.
(E) Sections were immunostained with anti-Runx2 and anti-ABC antibodies. A merged image (Runx2: red, ABC: green) is also indicated.
(F) Sections were immunostained with anti-Runx2 and anti-collagen I antibodies. A merged image (Runx2: red, collagen I: green) is also indicated.
See also Figure S1.
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1946either E9.5 or E11.5 NRX2/2 embryos (data not shown). These
results suggest that some steps of the Wnt/b-catenin pathway
may be inhibited in NRX2/2 embryos.
Abnormal Cardiovascular Development in NRX2/2 Mice
Fzd2 is dramatically upregulated during cardiogenesis [11].
Therefore, we examined cardiac morphology in the E18.5
embryos. As shown in Figure 2A, all NRX2/2 embryos (11 of
11 analyzed) showed a ventricular septal defect (VSD), a hole
between the right and left ventricles. More severe defects,e.g., persistent truncus arteriosus (PTA, a defect in the division
of the aorta and pulmonary arteries), were also observed in 3 of
11 embryos. Cardiac defects were not observed in the NRX+/+
and NRX+/2 embryos. The ventricular septum of the murine
heart divides two ventricles at about E14.5. In our study, on
E14.5, the NRX2/2embryos showed septal defects, whereas
theirNRX+/+ littermates showed fully formed septa (Figure 2B).
Similar defects during cardiovasculogenesis occurred in the
Dvl22/2 and Dvl32/2 mice [12, 13], suggesting that these
defects were due to reduction in Wnt/b-catenin signaling
Figure 2. Cardiovascular Defects in NRX2/2 Embryos
(A) Outlook andHematoxylin and Eosin (HE)-stained sections of heart fromE18.5 embryos. The arrowheads and an asterisk indicate ventricular septal defect
(VSD) and persistent truncus arteriosus (PTA), respectively.
(B) HE-stained sections of heart from E14.5 embryos. The arrowhead indicates VSD.
(C) Lysates of cells obtained from calvaria (E18.5) and heart (E10.5) were subjected to immunoblotting with the indicated antibodies. Relative expression
levels of the Dishevelled (Dvl) proteins are also indicated by normalizing the levels in NRX+/+ samples to 100.
(D) The expression levels of various known target genes of theWnt/b-catenin pathway (black bars) and theWnt/PCP pathway (gray bars) in embryonic heart
(E10.5) were determined by real-time polymerase chain reaction (PCR) experiments. The relative expression levels of NRX2/2 versus NRX+/+ are shown as
mean 6 standard error (SE; n = 3). p values were determined by the two-tailed Student’s t test (paired). *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S2.
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1947activity. Therefore, we examined b-catenin activation in the
embryonic heart by immunoblotting with the anti-ABC anti-
body; this activation was slightly but significantly reduced in
the NRX2/2 embryos (Figure 2C). Immunoblotting with an
anti-Dvl antibody, which recognizes all three mammalian Dvl
isoforms (Dvl1, Dvl2, and Dvl3) equally [4], revealed that the
cardiac Dvl protein levels were also dramatically reduced in
the heart of NRX2/2 embryos.
Neural crest cells contribute to cardiovascular development,
andWnt/b-catenin signaling is important for their development
and migration [14, 15]. We examined whether the distribution
of neural crest cells is perturbed in NRX2/2 embryos, but we
failed to detect any significant differences (Figures S2B–S2D).
Cardiovascular development is a complex process, and the
importance of the Wnt/b-catenin and Wnt/PCP pathways for
this process is well accepted [16]. To identify which pathway
was affected in NRX2/2 embryos, we performed quantitative
PCR analyses targeting various genes essential for cardiovas-
cular development. Among these genes, the expression of
Fzd2, Fgf10, Isl1, and Hand2, targeted by the Wnt/b-catenin
pathway [11, 17], wasmarkedly reduced in theNRX2/2 embry-
onic heart, but no significant differences were found in the
expression of Tgfb2 and Hspg2, target genes of the Wnt/
PCP pathway [18] (Figure 2D). Furthermore, no differences
were found in the activation status of Rac and Rho, important
mediators of the Wnt/PCP pathway [19] (data not shown).Wnt-Stimulated Signaling Activity Is Impaired in NRX2/2
Mouse Embryonic Fibroblasts
The results shown in Figure 2 suggest that the Wnt/b-catenin
pathway is impaired in several types of cells or tissues in
NRX2/2mice. Thus, we isolated mouse embryonic fibroblasts
(MEFs) and subjected them to more-detailed analyses at the
molecular level. We examined the expression levels of Dvl
and found their significant reduction in NRX2/2 MEFs relative
toNRX+/+ MEFs (Figure 3A). Because this antibody recognizes
all three Dvl isoforms (Dvl1–3) in mammals [4], we also per-
formed immunoblotting analyses using specific antibodies
against each Dvl isoform. As shown in Figure 3B, we could
confirm that Dvl2 and Dvl3 are expressed in MEFs and that
the protein levels of both of them are similarly reduced in
NRX2/2 MEFs. We then examined the ability of these MEFs
to activate Wnt/b-catenin signaling in response to exoge-
nously added Wnt ligands. The amount of active b-catenin
increased in NRX+/+ MEFs upon Wnt3a-conditioned medium
(Wnt3a CM) treatment, but no significant changes were
observed in the NRX2/2MEFs (Figure 3A). We also performed
reporter assays and reverse transcriptase-polymerase chain
reaction analyses to examine the downstream activation. As
shown in Figures 3C and 3D, the reporter activity and target
gene expression were increased in NRX+/+ MEFs upon Wnt
stimulation, but not in NRX2/2 MEFs. When we introduced
the NRX-expression vector to restore the expression of NRX
Figure 3. Impaired Activation of Wnt/b-Catenin
Signaling in NRX2/2 Mouse Embryonic Fibro-
blasts
(A) NRX+/+ and NRX2/2 mouse embryonic fibro-
blasts (MEFs) were transfected with nucleore-
doxin (NRX) expression vector (0.1 mg [+] or
2 mg [++], filled with empty vector to total 2 mg).
The cells were treated with Wnt3a-conditioned
medium (Wnt3a CM, +) or control CM (2), and
the lysates were subjected to immunoblotting
with the indicated antibodies. Relative expres-
sion levels of the Dvl proteins are also indicated
by normalizing the levels in NRX+/+ samples
to 100.
(B) Lysates of NRX+/+ and NRX2/2 MEFs, along
with lysates of COS7 cells ectopically expressing
Myc-Dvl1, Myc-Dvl2, or Myc-Dvl3, were sub-
jected to immunoblotting with the indicated
antibodies.
(C) MEFs were transfected with reporter vectors
(TOPFLASH or FOPFLASH) and NRX expression
vector, and the T cell factor (TCF)/lymphoid
enhancer factor (LEF) activity of MEFs treated
with Wnt3a CM (+) or control CM (2) was deter-
mined by luciferase assays (mean 6 SE, n = 5),
as reported previously [4]. p values were deter-
mined by the two-tailed Student’s t test (paired).
*p < 0.05.
(D) cDNAs prepared from MEFs treated as in (A)
were subjected to real-time PCR analyses as
a template to examine the expression levels of
c-Myc and CyclinD1. The relative expression
levels are shown as mean 6 SE (n = 4). p values
were determined by the two-tailed Student’s
t test (paired). *p < 0.05.
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1948in the NRX2/2 MEFs, the cells regained their potential to
respond to Wnt stimulation (Figures 3A, 3C, and 3D), con-
firming that the impaired response of NRX2/2 MEFs against
Wnt stimulation was caused by loss of NRX. Notably, much
stronger expression of NRX produced an opposite effect; the
MEFs did not respond to Wnt at all (Figures 3A, 3C, and 3D).
This is consistent with the original finding that overexpression
of NRX blocks the Wnt-induced accumulation of b-catenin [4].
NRX Inhibits Dvl Ubiquitination by KLHL12
Previous studies indicated that NRX plays an inhibitory role in
Wnt/b-catenin signaling, but our results obtained with NRX2/2
MEFs clearly highlight an opposite role. This differencemay be
related to the stability of the Dvl proteins. Therefore, we per-
formed pulse-chase analyses and identified a clear decrease
in the half-life of the Dvl proteins in NRX2/2MEFs (from 14.8 hr
to 7.6 hr, Figure 4A), indicating that Dvl degradation is acceler-
ated in NRX2/2 MEFs. Dvl directly interacts with Kelch-like 12
(KLHL12) in response to Wnt stimulation and is targeted forubiquitination by the E3 complex, com-
posed of Rbx1, Cullin3, and KLHL12
[3]. Therefore, we next examined the
ubiquitination status of Dvl. When we
treated MEFs with a proteasome inhib-
itor, MG132, the ubiquitination signal
of Dvl was observable in NRX+/+ MEFs.
In contrast, the level of Dvl ubiquitina-
tion was found to be much higher
in NRX2/2 MEFs (Figure 4B). Wnt3a
CM treatment significantly raised theubiquitination level of Dvl in NRX+/+ MEFs. However, we did
not observe a similar increase with stimulation of Wnt3a
in NRX2/2 MEFs, probably because significant ubiquitina-
tion had already occurred, irrespective of Wnt3a stimula-
tion. Next, we performed immunoprecipitation analyses to
examine the status of complex formation between Dvl and
KLHL12. The Dvl-KLHL12 interaction was found to be
augmented by Wnt3a stimulation in NRX+/+ MEFs. This is
consistent with the previous report [3], but a high-level interac-
tion was found to occur constitutively in NRX2/2 MEFs, even
though the levels of Dvl were lower (Figure 4C). To further
confirm the importance of KLHL12 in the regulation of Dvl
stability, we performed small interfering RNA (siRNA)-medi-
ated knockdown analyses against KLHL12. As shown in
Figure 4D, knockdown of KLHL12 resulted in a significant
increase in the Dvl protein levels in MEF cells, especially in
NRX2/2MEFs. Collectively, NRX appeared to function antago-
nistically with respect to KLHL12 to inhibit ubiquitination
of Dvl.
NRX Retains a Pool of Inactive Dvl
1949NRX Expels KLHL12 from Dvl
The previous report indicated that KLHL12 directly associates
with the C-terminal region of Dvl, but the central PDZ domain-
containing region of Dvl is also important for a strong interac-
tion [3]. NRX also directly binds to the central PDZ domain [4],
and we thus speculated that NRXmight compete with KLHL12
for Dvl and inhibit ubiquitination. To test this hypothesis, we
purified recombinant proteins of GST-Dvl1-His, His-NRX, and
His-KLHL12 and performed GST pull-down assays. We found
that the addition of His-NRX could expel His-KLHL12 from the
precipitate with GST-Dvl1-His (Figure 4E). The addition of His-
NRX-mut, which lacks binding affinity for Dvl1 [4], showed no
effect. We then performed in vitro ubiquitination assays to
confirm that the direct ubiquitination of Dvl by the Rbx1/
Cullin3/KLHL12 E3 complex is suppressed by NRX. For this
purpose, Rbx1, Cullin3, and KLHL12 proteins were expressed
in COS7 cells and purified by immunoprecipitation. Substrates
such as ubiquitin and GST-Dvl1-His, together with other
E1 and E2 proteins, were then added to initiate the ubiquitina-
tion reaction. We observed smear-positive signals of Dvl1 in
the higher molecular weight region. The ubiquitin-conjugated
form was confirmed by anti-Dvl immunoprecipitation and
subsequent anti-ubiquitin immunoblotting. When we added
His-NRX, most of the ubiquitinated form of Dvl1 disappeared,
whereas addition of His-NRX-mut had no effect (Figure 4F).
These results clearly indicate that NRX binds to Dvl1 and
protects it from ubiquitination by inhibiting the interaction
with KLHL12. We confirmed that both Dvl2 and Dvl3 can also
associate with NRX as Dvl1 (Figure 4G). This result suggests
the possibility that the stabilities of all Dvl isoforms are regu-
lated by the interaction with NRX, which is consistent with
the reduction of the protein levels of Dvl2 and Dvl3 in NRX2/2
MEFs (Figure 3B). As shown in Figure 4C, Wnt3a stimula-
tion strengthens the complex formation between Dvl and
KLHL12, suggesting that the interaction of NRX with Dvl might
be dynamically regulated. Indeed, coimmunoprecipitation
analyses showed that the amount of the NRX-Dvl complex
was decreased by Wnt3a stimulation (Figure 4H), which
presumably contributes to the promotion of ubiquitination
and degradation of Dvl by KLHL12.
The results shown in Figure 2C indicate that the amount of
endogenous Dvl was significantly reduced in cardiac cells
obtained from NRX2/2 embryos, without a significant differ-
ence in osteoblasts. The immunoblotting analyses showed
that the levels of KLHL12 were much higher in cardiac cells
than in osteoblasts (Figure 2C), which might explain the differ-
ence in the levels of Dvl protein in the absence of NRX.
Conclusions
We previously reported that NRX inhibits Dvl function [4].
Consistent with this view, osteoblasts obtained from NRX2/2
mice significantly activated Wnt/b-catenin signaling (Fig-
ure 1C). However, the signaling activity was paradoxically
decreased in cardiocytes of NRX2/2 mice (Figures 2C and
2D). These contradictory findings led to the discovery of the
novel role of NRX as a Dvl stabilizer.
Dysregulation of Wnt/b-catenin signaling is a major cause of
tumorigenesis. It should be noted that Dvl overexpression—
often observed in cancer cells [1]—can aberrantly activate
downstream signaling. In addition, it was recently reported
that ATDCprotein stimulates proliferation of pancreatic cancer
cells by stabilizing and increasing Dvl levels [2]. Normal cells
should thus be capable of regulating Dvl expression, and this
regulation may occur via KLHL12-mediated ubiquitinationsystem. On the other hand, sufficient Dvl levels are required
to activate the signal pathway following Wnt stimulation. In
such a delicately balanced situation, the competition between
NRX and KLHL12 for Dvl provides appropriate regulation.
In the resting state, NRX interacts with Dvl and blocks Dvl-
KLHL12 interaction to maintain a pool of inactive Dvl, which
is responsive to Wnt stimulation. Wnt stimulation then frees
Dvl from its association with NRX and induces the activation
of downstream signaling. Such NRX-free Dvl is vulnerable to
ubiquitination by KLHL12 and subsequent degradation, thus
avoiding persistent activation of Wnt/b-catenin signaling.Experimental Procedures
Targeted Disruption of NRX Gene
We used phage clones obtained from mouse 129/SvJ strain-derived
genomic library to generate the targeting vector. A linearized targeting
vector was electroporated into E14.1 embryonic stem (ES) cells, and
a portion of exon 3 and the entirety of exon 4 were replaced with a gene
cassette containing LacZ and neomycin-resistant genes. Southern blot
analyses were performed to confirm the proper recombination. The
genomic DNAs were digested with HindIII and hybridized with the 50 or 30
probes. Correctly targeted ES clones were used to generate germline
chimeras that were bred with C57BL/6J females.Isolation of Osteoblast Precursor Cells and MEFs
Primary osteoblast precursors were isolated as previously reported [6], with
the following minor modifications. Cells were isolated from calvaria of E18.5
NRX+/+ or NRX2/2 mice and were cultured in media (Dulbecco’s modified
Eagle’s medium plus 10% fetal bovine serum) supplemented with 100 mg/
ml ascorbic acid and 4 mM b-glycerophosphate. Differentiated osteoblasts
were detected by the alkaline phosphatase method, as previously
described [6]. Primary MEFs were isolated from E14.5 NRX+/+ or NRX2/2
mice and cultured by the standard method described elsewhere [20]. Plas-
mids and siRNAs were transfected into MEFs using the Neon transfection
system (Invitrogen). Duplex siRNAs against mouse KLHL12 were from Invi-
trogen, which targets the following sequences: KLHL12-siRNA1, 50- GGAC
UUCGUGUACACAGAAACAGUA-30; KLHL12-siRNA2, 50-CCGCCUCAGUU
CGGUGGAAUGUCUA-30; negative control, 50-AAAUGGCGUCGCGUUCCU
UUAGAGG-30.cDNAs
cDNAs of NRX, both wild type and mut (Cys205/208Ser), were generated in
the previous study [4]. cDNAs of all Dvl isoforms (Dvl1, Dvl2, and Dvl3) were
also generated in the previous study [4]. cDNAs of human KLHL12, Cullin3,
and Rbx1 were obtained by PCR using a cDNA library of HEK293 cells as
a template. The cDNA probe for Pitx2 was kindly provided by H. Shiratori
and H. Hamada [21].Antibodies
Anti-Dvl and anti-NRX rabbit polyclonal antibodies were generated in the
previous study [4]. The following commercially available antibodies were
also used: mouse monoclonal antibodies against active b-catenin (Milli-
pore), b-tubulin (Sigma), smooth muscle actin (Sigma), Dvl1 (Santa Cruz),
Dvl3 (Santa Cruz), ubiquitin (Santa Cruz), and FLAG-tag (Sigma); rabbit poly-
clonal antibodies against Runx2 (Santa Cruz), p75NTR (Promega), Dvl2 (Cell
Signaling), and Myc-tag (Santa Cruz); goat polyclonal antibody against
collagen I (Southern Biotechnology Associates); and chick polyclonal anti-
body against KLHL12 (Abcam).Immunohistochemistry of Mouse Embryos
The immunohistochemistry of whole-mouse embryos was performed as
previously described [22, 23], with the following minor modifications.
Embryos were fixed with ice-cold 2% paraformaldehyde (PFA) in phos-
phate-buffered saline (PBS) for 10 min. They were then blocked twice in
2% skim milk, 0.2% bovine serum albumin, and 0.3% Triton X-100 in ice-
cold PBS for 1 hr. For immunohistochemistry of sections, frozen sections
of E18.5mouse embryos were fixed in 4%PFA in PBS for 20min. The immu-
nostaining was performed as previously reported [24].
Figure 4. NRX Competes with KLHL12 to Suppress the Ubiquitination of Dvl
(A) Proteins in NRX+/+ and NRX2/2 MEFs were pulse-labeled with 35S and then cultured for the indicated time periods. Dvl was immunoprecipitated and
subjected to autoradiography.
(B)MEFswere treatedwithWnt3a CM (+) or control CM (2) andwithMG132 (or vehicle) for 10 hr, and the lysates were subjected to immunoprecipitation with
anti-Dvl antibody, followed by immunoblotting with the indicated antibodies.
(C) MEFs were treated with Wnt3a CM (+) or control CM (2) for 10 hr, and their lysates were subjected to immunoprecipitation with anti-Dvl antibody. The
precipitates were analyzed by immunoblotting with the indicated antibodies.
(D) MEFs were transfected with small interfering RNA (siRNA) against KLHL12 (1 or 2) or with control siRNA (2), and their lysates were subjected to immu-
noblotting with the indicated antibodies. Relative amounts of the Dvl proteins are also indicated by normalizing the levels of sample from control siRNA-
transfected NRX+/+ MEF to 100.
(E) Recombinant His-KLHL12 (expressed in bacteria), His-NRX (bacteria), and GST-Dvl1-His (insect cells) were purified, and the indicated amounts were
subjected to GST pull-down assays. The purity of the recombinant proteins was assessed by Coomassie staining. * denotes nonspecifically purified protein
that does not bind to Dvl.
(F) Recombinant GST-Dvl1-His proteins were subjected to in vitro ubiquitination assays with or without His-NRX (wild-type [WT] or Mut) proteins. The reac-
tion mixtures were then subjected to direct immunoblotting with anti-Dvl antibody or immunoprecipitation with anti-Dvl antibody, followed by anti-Ubi
immunoblotting.
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1951In Vitro Ubiquitination Assays
In vitro ubiquitination assays of recombinant Dvl1 proteins were performed
as previously described [3], with the following minor modifications. E3
complex components (FLAG-KLHL12, Myc-Cullin3, and Myc-Rbx1) were
ectopically expressed in COS7 cells and purified by anti-FLAG immunopre-
cipitation. The complex was incubated for 2 hr at 37C with 2 mg of purified
GST-Dvl1-His proteins, 20 mg ubiquitin (Sigma), 100 ng E1 (His-UBE1,
Boston Biochem), and 1 mg E2 (GST-UbcH5a, Boston Biochem).
Microarray Analyses
Microarray analyses were performed according to previous studies [25, 26].
Total RNAs were extracted from E9.5 and E11.5 embryos derived from
NRX+/+ and NRX2/2 mice by using the RNeasy extraction kit (QIAGEN).
Two dye-swapped experiments were performed by hybridizing complimen-
tary RNA (cRNA) labeled with either Cy-3 or Cy-5 (Perkin-Elmer) onto
a Whole Mouse Genome Oligo Microarray (G4122A; Agilent Technologies).
The signature genes (p < 0.05, two-tailed Student’s t test, paired) with mean
fold changes > +2.0 (more than twice) or < 22.0 (less than half; + indicates
upregulated and2 indicates downregulated for each absolute value) at both
stages were subjected to further evaluation.
Real-Time Polymerase Chain Reaction
Real-time polymerase chain reaction (PCR) experiments were performed
with MiniOpticon (Bio-Rad) using the iQ SYBR green Supermix (Bio-Rad).
The quality of the final PCR product was checked by agarose gel electro-
phoresis, and it was confirmed that there were no obvious nonspecifically
amplified DNAs. The primers used are as follows: Fzd2 (50-CGCTTCCG
TTCCCTTCTCTC-30 and 50-ACACATAACACACAACCCAATCC-30), Fgf10
(50-CAGTAAGACACGCAAGCATTTACTG-30 and 50-AATCTGATCCAATTCTT
CCATGGT-30), Isl1 (50-TAAGCATGCCTGTAGCTGGTT-30 and 50-GATGGAT
CTCAAAAAAATGGTAAAGAG-30), Hand2 (50-CCACCAGATACATCGCCTAC
CT-30 and 50-CTTTCACGTCGGTCTTCTTGATC-30), Tgfb2 (50-GCGAAGAG
CTCGAGGCGAGAT-30 and 50-GAGAATGGTCAGTGGTTCCAGAT-30), and
HSPG2 (50- TGATGCCCCTGGGCAATACGG-30 and 50-CTGTGCTGGTCC
GAACCTCG-30). The primers for c-Myc, Cyclin D1, and GAPDH were
described previously [4].
Accession Numbers
The microarray data have been deposited in the Gene Expression Omnibus
(NCBI-GEO) database under accession number GSE21954.
Supplemental Information
Supplemental Information includes two figures and can be found with this
article online at doi:10.1016/j.cub.2010.09.065.
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